SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.37-8.4%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (9863)5/9/1999 9:45:00 AM
From: William L. Molair II  Read Replies (2) of 17367
 
Robert / George /etc.

I am starting to wonder if the better investment move, might be to sell XOMA, wait for the announcement, and then make a decision whether or not to repurchase shares?

Given the lack of investor interest in biotechs (especially small ones), even if the news is good, Xoma stock may trade up some on positive mengio news - but still may offer a decent reentry point. If the news is bad or ho-hum, we could see sub $1 per share.

Comments / Thoughts / and Opinions appreciated ...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext